Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States.
J Manag Care Spec Pharm
; 27(7): 891-903, 2021 Jul.
Article
in En
| MEDLINE
| ID: mdl-34185564
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oxazines
/
Piperazines
/
Pyridones
/
HIV Infections
/
HIV-1
/
Lamivudine
/
Heterocyclic Compounds, 3-Ring
Type of study:
Health_economic_evaluation
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
J Manag Care Spec Pharm
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: